Top Markets
#1 Islamic Coin Islamic Coin +158.25%
#2 Glidr Glidr +58.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#4 Movement Movement +10.52%
#5 Palladium Network Palladium Network +8.73%
#6 Pons Pons +7.33%
#7 Cryptopia Cryptopia +6.10%
#8 Victoria VR Victoria VR +5.49%
#9 DMT-NAT DMT-NAT +5.17%
#10 Lisk Lisk +4.83%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Nanomix Corporation Nanomix Corporation

Nanomix Corporation

NNMX
Rang in Aktien #41810
Boston Therapeutics, Inc. focuses on the discovery, production, and... Boston Therapeutics, Inc. focuses on the discovery, production, and commercialization of therapeutic drugs aimed at fulfilling critical unmet medical needs in the areas of diabetes and inflammatory diseases. The company's pipeline features BTI-320, a non-systemic, carbohydrate-based tablet currently in Phase II clinical trials, which is being developed to reduce post-meal blood glucose levels in patients with pre-diabetes and type 2 diabetes. They also have IPOXYN, an injectable medication designed to prevent tissue necrosis and address conditions caused by low oxygen, such as diabetic foot ulcers and other related vascular or neurological complications. Additionally, Boston Therapeutics is progressing with BTI-410, a peptide injectable compound also in Phase II clinical development, intended to stimulate beta cell maturation in the pancreas. This could potentially serve as a new insulin-producing cell agent for individuals with type 2 diabetes and type 1 patients on immunosuppression therapy following a kidney transplant. Complementing its pharmaceutical endeavors, the company offers SUGARDOWN, a non-systemic, polysaccharide-based dietary supplement designed to support healthy blood glucose management, and OXYFEX, a veterinary application that acts as an oxygen delivery agent, similar to a red blood cell replacement, for treating ischemia, trauma, and blood loss during surgical procedures. The firm further extends its offerings to include Automatic Retinal Image Analysis (ARIA), a diagnostic tool used for screening cardiovascular risks, including stroke. Boston Therapeutics, Inc. maintains its headquarters in Lawrence, Massachusetts.
Aktienkurs
$0.0002
Zuletzt synchronisiert: 2025-04-08
Marktkapitalisierung
$9.80K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Nanomix Corporation (NNMX)

Kategorie

Healthcare
Aktien-Split-Historie für Nanomix Corporation (NNMX)
Die Aktie Nanomix Corporation (Symbol: NNMX) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 13, 2026 statt.
Eine NNMX-Aktie, die vor dem Aug 13, 2026 gekauft wurde, entspricht heute 0 NNMX-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 9 x285
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 9 x162
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 7 x127
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 2 x4
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 3 x12
US